Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Email alerts

Application overview

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Journal of psychopharmacology (Oxford, England)
Date
2022-02-01
Source
PubMed
DOI
10.1177/02698811211073759
PubMed
35166158

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression2026-11-01The New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy2026-10-01Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review2026-09-10No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study2026-07-23Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex2026-06-28DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish2026-06-18Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis2026-06-15Psilocybin: Chemical Foundations and Emerging Therapeutic Potential2026-06-01Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial2026-06-01Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats2026-06-01Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial2026-05-27Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression2026-05-15The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies2026-03-19Explainable AI framework for psilocybin depression treatment optimization2026-03-16Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy2026-03-01Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression2026-03-01

Related papers